Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma (Q46432866)
Jump to navigation
Jump to search
scientific article published on 11 April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma |
scientific article published on 11 April 2005 |
Statements
1 reference
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma (English)
1 reference
C Manegold
1 reference
J Symanowski
1 reference
U Gatzemeier
1 reference
M Reck
1 reference
J von Pawel
1 reference
C Kortsik
1 reference
K Nackaerts
1 reference
P Lianes
1 reference
N J Vogelzang
1 reference
11 April 2005
1 reference
1 reference
16
1 reference
6
1 reference
923-927
1 reference
Identifiers
1 reference
1 reference